Challenges and future of renal replacement therapy

Hemodialysis International

Volumn 10, Issue SUPPL. 1, 2006, Pages

  de Francisco, Angel L M ^a   Piñera, Celestino ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Bioartificial kidney; Cloning; Future; Hemodialysis technology; Organogenesis

Indexed keywords

ACUTE KIDNEY FAILURE; AGING; ARTICLE; BIOARTIFICIAL ORGAN; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL TRIAL; COMORBIDITY; CONTINUOUS HEMOFILTRATION; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIALYSIS MEMBRANE; EUROPE; FEASIBILITY STUDY; HEMODIAFILTRATION; HEMODIALYSIS; HISTOCOMPATIBILITY; HUMAN; INCIDENCE; MEDICAL TECHNOLOGY; MOLECULAR CLONING; MORBIDITY; MORTALITY; ONLINE SYSTEM; ORGANOGENESIS; OUTCOMES RESEARCH; PH; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; RENOVASCULAR DISEASE; RISK FACTOR; SAFETY; UNITED STATES; VASCULAR ACCESS;

FORECASTING; HUMANS; KIDNEY, ARTIFICIAL; ONLINE SYSTEMS; RENAL REPLACEMENT THERAPY;

EID: 33144472526     PISSN: 14927535     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2006.01185.x     Document Type: Article

References (27)

1. van Dijk WP, Jager KJ, de Charro F, et al. Renal replacement therapy in Europe: The results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant. 2001; 16:1120-1129.
2. Rayner HC, Pisoni RL, Bommer J, et al. Mortality and hospitalization in haemodialysis patients in five European countries: Results from the dialysis outcomes and practice patterns study (DOPPS) nephrol dial transplant. 2004; 19:108-120.
3. U.S. Renal Data System. USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases; 2003.
4. Henderson LW. Future developments in the treatment of end-stage renal disease: A North American perspective. Am J Kidney Dis. 2000; 35:S106-S116.
5. Ellis PW, Malchesky PS, Magnusson MO, Goormastic M, Nakamoto S. Comparison of two methods of kinetic modeling. Trans Am Soc Artif Intern Organs. 1984; 30:60-64.
6. Locatelli F, Buoncristiani U, Canaud B, Kohler H, Petitclerc T, Zucchelli P. Haemodialysis with on-line monitoring equipment: Tools or toys? Nephrol Dial Transplant. 2005; 20:22-33.
7. Eknoyan G, Beck GJ, Cheung AK. The Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002; 347:2010-2019.
8. Henderson LW, Beans E. Successful production of sterile pyrogen-free electrolyte solution by ultrafiltration. Kidney Int. 1978; 14:522-525.
9. Canaud B, Imbert E, Kaaki M, et al. Clinical and microbiological evaluation of a postdilutional hemofiltration system with in-line production of substitution fluid. Blood Purif. 1990; 8:160-170.
10. Canaud B, Nguyen QV, Lagarde C, Stec F, Polaschegg HD, Mion C. Clinical evaluation of a multipurpose dialysis system adequate for hemodialysis or for postdilution hemofiltration/hemodiafiltration with on-line preparation of substitution fluid from dialysate. Contrib Nephrol. 1985; 46:184-186.
11. Pizzarelli F, Cerrai T, Dattolo P, Tetta C, Maggiore Q. Convective treatments with on-line production of replacement fluid: A clinical experience lasting 6 years. Nephrol Dial Transplant. 1998; 13:363-369.
12. Beerenhout CH, Kooman JP, Luik AJ, Jeuken-Mertens SG, Van Der Sande FM, Leunissen KM. Optimizing renal replacement therapy - a case for online filtration therapies? Nephrol Dial Transplant. 2002; 17:2065-2070.
13. Locatelli F, Marcelli D, Conte F, et al. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. Kidney Int. 1999; 55:286-293.
14. Locatelli F, Marcelli D for the Registro Lambardo Dialisi Trapianto, et al. Comparison of mortality in ESRD patients on convective and diffusive extracorpeal treatments. Kidney Int. 1999; 55:286-293.
15. Canaud B, Bragg-Gresham JL, Marshall MR, et al. Patients receiving hemodiafiltration or hemofiltration have lower mortality risk than patients receiving hemodialysis without replacement fluid (HD) in Europe: The Dialysis Outcomes and Practice Patterns Study (DOPPS) [abstract]. J Am Soc Nephrol. 2003; 14:31A.
16. Cheung AK, Levin N. Effect of high flux (HF) hemodialysis (HD) membranes on clinical outcomes: Results from the HEMO study [abstract]. J Am Soc Nephrol. 2002; 13:432A.
17. Maduell F, del Pozo C, Garcia H, et al. Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant. 1999; 14:1202-1207.
18. Grillo P, Bonforte G, et al. Haemofiltration with substitution of fluid prepared on line decreases rHuepo consumption. Nephrol Dial Transplant. 1999; 14:A207.
19. Wizeman V, Lotz C, Techert F. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study. Nephrol Dial Transplant. 2000; 15(Suppl 1):43-48.
20. Canaud B, Bosc JY, Leray-Moragues H, et al. On-line haemodiafiltration. Safety and efficacy in long-term clinical practice. Nephrol Dial Transplant. 2000; 15(Suppl 1):60-67.
21. Saran R, Canaud BJ, Depner TA, et al. Dose of dialysis: Key lessons from major observational studies and clinical trials. Am J Kidney Dis. 2004; 44(Suppl 3): 47-53.
22. Kooistra MP. Frequent prolonged home haemodialysis: Three old concepts, one modern solution. Nephrol Dial Transplant. 2003; 18:16-19.
23. Locatelli F, Buoncristiani U, Canaud B, Köhler H, Petitclerc T, Zucchelli P. Dialysis dose and frequency. Nephrol Dialy Transplant. 2005; 20:285-296.
24. Humes HD, Weitzel WF, Bartlett RH, et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int. 2004; 66:1578-1588.
25. Hammerman MR. Xenotransplantation of renal primordia. Curr Opin Nephrol Hypertens. 2002; 11:11-16.
26. Lanza RP, Chung HY, Yoo JJ, et al. Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol. 2002; 20:689-696.
27. Cascalho M, Ogle BM, Platt JL. Xenotransplantation and the future of renal replacement. J Am Soc Nephrol. 2004; 15:1106-1112.